ArticleMayo Clinic proceedings. Innovations, quality & outcomes2026
Effect of Handheld Echocardiography by Trained Advanced Practice Providers on Heart Failure Management and Readmissions.
Article in Mayo Clinic proceedings. Innovations, quality & outcomes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate the effect of point-of-care ultrasound using handheld echocardiography (HHE) by trained advanced practice providers (APPs) on congestive heart failure (CHF) readmissions. Patients and Methods: This prospective cohort study comprised 140 consecutive patients with CHF admitted under cardiology service and involved an intervention group (n=67), in whom APPs trained in HHE assessed left ventricular ejection fraction and right atrial pressure (RAP) using HHE, and a control group (n=73) identified retrospectively during concurrent period, who received standard APP-delivered care without HHE. Advanced practice providers incorporated HHE findings into guideline-directed medical therapy (GDMT) decisions. Clinical characteristics, GDMT, length of stay, and 30-day all-cause and CHF readmissions were evaluated. Results: Baseline demographic characteristics and medical therapy were similar except higher diabetes incidence in the HHE group (59.70% vs 32.88%; Conclusion: In patients hospitalized with CHF, the addition of HHE-guided assessment by APPs was associated with lower predischarge RAP and reduced 30-day readmissions for CHF exacerbations. These hypothesis generating findings require validation in larger randomized trials.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.